Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome (LDN-CRPS)
Sponsor: Stanford University
This NA trial investigates Complex Regional Pain Syndrome and is currently actively recruiting participants. Stanford University leads this study, which shows 16 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
16 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
-
Dec 2024 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 11 earlier versions
-
Oct 2023 — Dec 2023 [monthly]
Recruiting NA
-
May 2023 — Oct 2023 [monthly]
Recruiting NA
-
Sep 2022 — May 2023 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
-
Jun 2021 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .